Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates

► rMV vector immunization primes cellular responses to an adenovirus vector heterologous boost. ► rMV priming is highly effective for suboptimal doses of the boosting vector. ► Recombinant MV retains robust measles-specific humoral and cellular immunogenicity.